Neurizon Therapeutics Ltd: Neurizon updates on NUZ-001 IND Application

Jan 17 06:59

Neurizon Therapeutics Ltd: Change of Share Registry

Jan 16 05:19

Neurizon Therapeutics Ltd: Neurizon Files IND Application to Support HEALEY ALS Trial

Dec 18, 2024 06:13

Neurizon Therapeutics Ltd: Neurizon Granted OMPD for NUZ-001 in Europe

Dec 17, 2024 05:52

Neurizon Therapeutics Ltd: Positive 8-month Interim Data from OLE Study

Dec 16, 2024 06:34

Neurizon Therapeutics Ltd: Neurizon Receives Additional R&D Tax Incentive Rebate

Dec 11, 2024 10:47

Neurizon Therapeutics Ltd: Notice of Company Update Webinar

Dec 5, 2024 06:29

Neurizon Therapeutics Ltd: Correction to text positioning error in announcement

Nov 15, 2024 15:30

Neurizon Therapeutics Ltd: NUZ-001 Reduces Aggregation of Key ALS Disease Target

Nov 15, 2024 06:50

Neurizon Therapeutics Ltd: Positive opinion received on OMPD for NUZ-001 in Europe

Nov 11, 2024 06:39

Neurizon Therapeutics Ltd: Appendix 4C & Quarterly Update

Oct 31, 2024 06:21

Neurizon Therapeutics Ltd: Neurizon Presents Phase 1 MEND Study Data at NEALS Meeting

Oct 25, 2024 06:55